Fig. 3. Zonisamide mitigates apoptosis in diabetic hearts.
a, b TUNEL assay results and quantification of cell apoptosis in the Con, T2DM, and T2DM + ZNS groups (green, TUNEL staining; blue, DAPI staining). c–f Western blotting results and quantitative analysis of Bcl-2, Bax, caspase-3, and cleaved caspase-3 expression. All values are the fold changes normalized to their control group. The data are presented as the means ± SEM (n = 4-5). *P < 0.05, **P < 0.01 vs. Con; #P < 0.05, ##P < 0.01 vs. T2DM.